05:29 PM EDT, 06/20/2024 (MT Newswires) -- Avrobio ( AVRO ) has closed its merger with clinical-stage biotechnology company Tectonic Therapeutic, Tectonic said Thursday.

The merged entity will operate as Tectonic Therapeutic, with its shares expected to start trading on the Nasdaq Global Market Friday under the TECX ticker symbol.

Tectonic said it expects its cash, cash equivalents and investments of about $181 million to fund its operation into mid-2027.

Price: 1.4400, Change: +0.04, Percent Change: +2.86